Raymond James Trust’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$205K Buy
+2,867
New +$202K ﹤0.01% 1236
2023
Q1
Sell
-3,139
Closed -$233K 1170
2022
Q4
$233K Buy
+3,139
New +$214K 0.01% 972

Other funds holding GMED

Raymond James Trust's GMED Position: Q3 2024 in Review

Raymond James Trust opened a new position in Globus Medical (GMED) in Q3 2024: 2,867 shares worth $205K. The stake represents ﹤0.01% of the portfolio and ranks #1236 among its holdings. This is a return to the name: Raymond James Trust previously reported a position in GMED as recently as Q4 2022.

Raymond James Trust first reported a position in GMED in Q4 2022 and has held it in 2 quarters since. The position peaked at $233K in Q4 2022. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

  • Raymond James Trust held 2,867 shares of Globus Medical worth $205K as of Q3 2024.
  • Globus Medical was a new Raymond James Trust position in Q3 2024.
  • Globus Medical made up ﹤0.01% of Raymond James Trust's portfolio in Q3 2024, its #1236 holding.
  • Raymond James Trust first reported a position in Globus Medical in Q4 2022 and has held it in 2 quarters since.
  • Raymond James Trust's Globus Medical position peaked at $233K in Q4 2022.
  • 449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.